Lead development · 11/16/2026, 9:59:04 AM UTC
Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
Event tracker · Stocks
NewsMatic is following verified developments and related reports from trusted publishers.
Read the lead brief →Lead development · 11/16/2026, 9:59:04 AM UTC
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.